Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Coronavirus FAQ: I'm confused by the new testing advice! Do it once, twice ... thrice?

The FDA issued revised guidance about how often to test after exposure to someone with COVID or after symptoms occur. It's not exactly the same as what the CDC says. What's the best way to proceed?

WEKU

Can Medicare negotiate the price of prescription drugs?

The ten most expensive drugs covered by Medicare are responsible for about a fifth of total Medicare drug spending.

USAFacts

Most of nation 'will get Covid by year's end'

It should take about three years from the emergence of Covid-19 for it to infect most of Thailand's population, a virologist said on Thursday citing past surveillance of the coronavirus.

Bangkok Post

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has accepted the Menarini Group and Radius Health’s (NASDAQ:RDUS), New Drug Application (NDA) for elacestrant for patients with ER+/HER2- advanced or metastatic breast cancer. The agency has granted Priority Review designation and assigned a target action date of February 17, 2023. Radius Health…

Benzinga

The FDA recommends 3 home tests if you're exposed to COVID to boost accuracy

Previously, the FDA had advised taking two rapid antigen tests over two or three days to rule out infection. But the agency says new studies suggest that protocol can miss too many infections.

WEKU

FDA: Take 3 home tests if exposed to COVID to boost accuracy

New U.S. recommendations call for three home tests for people exposed to COVID-19 to improve accuracy

The Independent UK

Citing lower risk, CDC changes COVID-19 exposure guidelines - Roll Call

Even as hospitalizations tick upward, CDC releases eased measures aimed at reducing pandemic-era barriers to everyday activity.

Roll Call

Read news from The Economist, FT, and more,
with one subscription

Monkeypox vaccine maker warns Biden administration against strategy to stretch supply

Plan to multiply 440,000 doses into 2 million is ‘safe and effective’ and will go ahead says HHS secretary

The Independent UK

Benzinga Before The Bell: iPhone 14 Might Be Costlier, Coinbase Face Another SEC Probe, Binance Sees Crypto User Growth And Other Top Financial Stories Thursday, August 11

Reuters Binance Says Worldwide Inflation Is Driving Crypto User Growth

Benzinga

Fake test kits, medical products seized

Fake Covid-19 antigen test kits and other medical gear, worth about 2 million baht, were seized during police-led raids in Nakhon Pathom and Nonthaburi provinces on Thursday.

Bangkok Post

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

Bristol Myers Squibb (NYSE:BMY) and 2seventy bio (NASDAQ:TSVT) announced positive topline results from KarMMa-3, a Phase 3 study evaluating Abecma (idecabtagene vicleucel) compared to standard combination regimens in adults with multiple myeloma that is relapsed and refractory. Bristol Myers shares traded in a range of $73.95 to $75.32 on a day volume…

Benzinga

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

This drug could help treat monkeypox. Some patients have struggled to get it

Joseph Cassara decided to head back to the emergency room when the pain made it unbearable to swallow.

Los Angeles Times

Benzinga Before The Bell: Elon Musk Sells $6.8B Tesla Shares, Nio Begins ES7 Test Drives, Coinbase Accused Of Misleading Investors And Other Top Financial Stories Wednesday, August 10

Wall Street Journal

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

ECOR: Consistent Expansion of Distribution

By John Vandermosten, CFA NASDAQ:ECOR READ THE FULL ECOR RESEARCH REPORT

The Philadelphia Inquirer

How to tell if your COVID test is expired

Did you stock up on rapid at-home COVID-19 tests only to realize they all expire much sooner than you expected?

Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Tribune News Service

Merck & Co.’s Januvia, a popular diabetes drug, was found to be contaminated with a potential carcinogen.

Get all your
news in one place.

100’s of premium titles.
One news app.

Los Angeles Times

As monkeypox cases spiral, US will stretch supply of vaccine by giving smaller doses

As monkeypox cases continue to increase among high-risk people, federal officials on Tuesday announced they will stretch limited vaccine supplies by giving just one-fifth the current dosage.

Al Jazeera

White House announces steps to boost monkeypox vaccine supply

The FDA has issued emergency authorisation for a dosage technique that would allow more shots of vaccine per vial.

Benzinga

Recap of Tuesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder (MDD). Relmada shares traded in a range of $26.02 to $27.96 on a day volume of 173.79 thousand shares, closed regular trading…

WEKU

With supplies low, FDA authorizes plan to stretch limited monkeypox vaccine doses

The Biden administration is allowing the shot to be given between layers of skin — a method that only requires a fifth of the full dose — in order to increase vaccinations and slow the outbreak.

The Independent UK

US will stretch monkeypox vaccine supply with smaller doses

U.S. health officials are endorsing a new monkeypox vaccination strategy designed to stretch limited supplies by allowing health professionals to vaccinate up to five people — instead of one — with each vial

Benzinga

Dow Drops Over 100 Points; Verona Pharma Shares Jump

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 100 points on Tuesday.

Benzinga

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.

1 … 170 171 172 173

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.